Westport Innovations Rallies on Acquisition Chatter and 3 Stock Analyses Making Rounds
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Current Price: $57.18
William Blair has increased the company’s price target due to increased confidence in BMN-701 after the Lysosomal Disease Network WORLD Symposium. The firm still names BioMarin as a top pick for 2013 and reiterates its Outperform rating on stock.
Digital Realty Trust Inc. (NYSE:DLR): Current Price: $63.22
JMP Securities is convinced that recent concerns about Digital Realty caused a compelling entry point in the stock and the firm is upbeat in regards to the long-term outlook for data center demand. The firm keeps its Outperform rating and a $75 price target on the stock.
Westport Innovations Inc. (NASDAQ:WPRT): Current Price: $31.42
According to JPMorgan, Westport Innovations shares rallied on Friday resulting from a report that Cummins (NYSE:CMI) is considering an acquisition of the company at $42 per share. The firm believes that the potential deal is highly unlikely and adds that the $42 per share price makes little sense. JPMorgan reiterates its Neutral rating on the stock.
CapLease, Inc. (NYSE:LSE): Current Price: $6.11
The company provided weaker than expected guidance, but JMP Securities continues to believe that CapLease is one of the more compelling investment opportunities across the REIT sector as a result of what the firm believes is its strong execution. The firm believes that the stock’s multiple will expand and it keeps its Outperform rating.